Linzodin Syrup

LINZOLIDE

CLEAR CHOICE TO TREAT INFECTIONS CAUSED BY MRSA

OFFERS A FAVORABLE SAFETY PROFILE IN A BROAD RANGE OF PATIENTS

Exhibits good activity against Staphylococci including strains resistant to Methicillin Glycopeptides & other antibacterial agents. Highly active against penicillin resistant S. Pneumonaei, Vancomycin-resistant E.Faecalis, Corynebacterium Sp, Moraxella Catarrhalis and Bacteroides Fragilis. Excellent option with significant resistant gram positive bacteremic infections. Safe and efficacious for Nosocomial Pneumonia.

INDICATIONS :

• CAP
• UTI
• SSTI
• BACTERAEMIA
• DIABETIC FOOT INFECTIONS
• BONE & BONE MARROW INFECTIONS

DOSAGE & ADMINISTRATION:

Adults : 1 Tab (400 mg / 600 mg) twice a day for 10-14 days.

Children <12 Years : 20 mg – 30 mg / kg body weight in 2 divided doses in a day for 10-14 days.

MRP Rs. 385